CURRICULUM VITAE. Lecturer (Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al- Azhar University, Cairo, Egypt)

Similar documents
Curriculum vitae Personal details

Teacher. Biology & Biotechnology Department, Faculty of Science, An- Najah National University, Nablus, Palestine.

Teacher. Biology & Biotechnology Department, Faculty of Science, An- Najah National University, Nablus, Palestine.

Curriculum Vitae; Dr. Rabeay Y. A. Hassan

Computational methods in drug discovery

B.S. in Biology, 1994, Magna Cum Laude, Hebrew University, Jerusalem, Israel

Introduction to Drug Design and Discovery

Computer Aided Drug Design. Protein structure prediction. Qin Xu

Self-financed Coursework Advanced Workshop on Molecular Docking, Virtual Screening & Computational Biology 13 th - 15 th March 2019

CENTRE FOR BIOINFORMATICS M. D. UNIVERSITY, ROHTAK

What s New in LigandScout 4.4

CURRICULUM VITAE. Dr. Hanan Ramadan Hamad Mohamed

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

CURRICULUM VITAE. Beena Krishnan

Secretary of the National Pharmacovigilance Committee. Deputy Head of Adverse Drug Reactions Dept

Expressive. Bacterial surface display for the identification of active ingredients for the pharmaceutical and cosmetics industry

Ligand docking. CS/CME/Biophys/BMI 279 Oct. 22 and 27, 2015 Ron Dror

Investigating the Molecular Basis for the Constitutive Activity of the Nuclear Hormone Receptor CAR

A hybrid structural approach to analyze ligand binding by the 5-HT4. receptor

What s New in Discovery Studio 2.5.5

A New Cellular and Molecular Engineering Curriculum at Rice University

CURRICULUM VITAE. Dr. Adel Zein El Dein Mohammed Moussa

CURRICULUM VITAE. Name: Abdel Hamid Basheer Mohammed Helali Job Title: Associate Professor Date of Birth: 22 Oct., 1951

Fathy Abd ElRahman Ahmed Faramawi

Ligand docking and binding site analysis with pymol and autodock/vina

Biomedical Sciences Graduate Program

Outline. Background. Background. Background and past work Introduction to present work ResultsandDiscussion Conclusions Perspectives BIOINFORMATICS

In Silico DNA-Based Aptamer Selection and Construction

Biomolecular Characterization for Rational Drug Design. Maria João Romão

4/10/2011. Rosetta software package. Rosetta.. Conformational sampling and scoring of models in Rosetta.

Curriculum Vitae. P.O 2455, Riyadh 11451, SAUDI ARABIA

Microbial Biotechnology Doctorate Program Specification (2015/ 2016)

"Large-Scale Information Extraction for Biomedical Modelling and Simulation"

CURRICULUM VITAE. Current Position: Post-Doctoral research associate at Colorado State University.

Course Code(s): AB023Q01UV Full-time 4 Years AB023Q31UV Part-Time 8 Years

Products & Services. Customers. Example Customers & Collaborators

Computational Drug Design

Secretary of the National Pharmacovigilance Committee. Deputy Head of Adverse Drug Reactions Dept

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

Prof. Dr. Dr. Karl Siegfried Boos. 18 th September th October 2014

BIOCHEM + MOLE BIOLOGY- BC (BC)

Computational Drug Discovery

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

The University of Jordan. Accreditation & Quality Assurance Center. COURSE Syllabus

Homology Modeling of the Chimeric Human Sweet Taste Receptors Using Multi Templates

UCL courses that require ATAS

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas

4.3 Qualification Expertise (Canada)

Is the grass greener on the other side.? Academia to Industry Stephen B. Helliwell

Full Name: Mysara Ahmed Mohamed Babiker Surname: Mohamed Date of Birth: 1951 Nationality: Sudanese

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab

Curriculum Vitae of KHANDKER MOHAMMAD KHALID

Careers in Novogene Europe Contact: Ms. Kelly Lu, HRBP Novogene Europe

IJENS-RPG [IJENS Researchers Promotion Group] ID: IJENS-1263-Attalla. Curriculum Vitae. Assistant Prof. Dr. Eng. Mohamed Attalla

Ossama Ali Abdullatef Mohammed

Investigating the interactions of FCS-304 and other Monoamine Oxidase (MAO) A Inhibitors Using Molecular Docking

CURRICULUM VITAE. Mohammad A. Alsenaidy, M.Sc., Ph.D.

DRUG DISCOVERY AND DEVELOPMENT-PRECLINICAL ASPECTS

B.PHARMACY - SEMESTER I

RNA as drug target: docking studies. Florent Barbault ITODYS CNRS (UMR7086) Univ. Paris7 Group of Molec. Modeling & Chem. Info.

Science June 3, 1988 v240 n4857 p1310(7) Page 1

Curriculum Vitae. Education and Credentials

This place covers: Methods or systems for genetic or protein-related data processing in computational molecular biology.

EDUCATIONAL BACKGROUND

CS/BioE/Biophys/BMI/CME 279 Computational biology: Structure and organization of biomolecules and cells

WCMM LiU symposium Linköping 7 8 December 2017 Lecture hall Hugo Theorell, North entrance, level 9, Campus US

CURRICULUM VITAE. NAME: DR. JUMA GERALD, BSc. MSc. Ph.D

The Confo body technology, a new platform to enable fragment screening on GPCRs

Ph.D in (Insect Molecular Biology) 2004: From The Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Ishikawa, Japan.

Targeting of the disease related proteome by small molecules

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.

Europass Curriculum Vitae

THE GADEN MEMORIAL LECTURE

Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin

Rational Drug Designing for Drug Target Alanine Racemase (Alr) of Mycobacterium tuberculosis

Structural and functional. characterization of. G protein-coupled adenosine receptors. and the orphan receptor GPR143

Can inhibitors of HIV integrase work on HCV polymerase?

PackAssistant Software for Optimal Loading of Containers

Tobias Ebert. Curriculum Vitae. January University of Mannheim phone: A5,6 (section A)

Temple of pharma - Speciality Chemicals Magazine

FOLDING CYSTEINE-RICH MINIPROTEINS

Pharmacophore modeling, virtual computational screening and biological evaluation studies

Pharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life

CURRICULUM VITAE. VINCENT ODUOL OCHIENG, B.Sc., M.Sc., Ph.D.

or

Quo vadis Drug Discovery

Nucleic acids. How DNA works. DNA RNA Protein. DNA (deoxyribonucleic acid) RNA (ribonucleic acid) Central Dogma of Molecular Biology

Module 1 overview PRESIDENTʼS DAY

Dennis Wright, Ph.D. Professor of Medicinal Chemistry NPDD Initiative UCONN School of Pharmacy University of Connecticut

Information Page. A List of Secondary Structure Prediction Servers

From mechanism to medicne

EDUCATION PRACTICAL AND PROFESSIONAL EXPERIENCE

GPCR-DIRECTED LIBRARIES FOR HIGH THROUGHPUT SCREENING SAGAR POUDEL

Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences

RESUME. Tricht(D.T) Tiruchirappalli Pin : Cell :

6. Amsterdam Institute for Molecules, Medicine and Systems (AIMMS) VU University Amsterdam

National Academic Reference Standards (NARS) Pharmacy. January st Edition

ELE-DG-E-1986 Manager of Wind Energy Applications PERSONAL DATA EDUCATION LANGUAGES COMPUTER SKILLS TRAINING COURSES AND CERTIFICATIONS

Recent years have witnessed an expansion in the disciplines encompassing drug

RMSD-BASED CLUSTERING AND QR FACTORIZATION. Rob Swift, UCI Tuesday, August 2, 2011

Transcription:

CURRICULUM VITAE Farag F. S. Selim, PhD CONTACT DETAILS Name: Farag Farouk Sherbiny Selim Nationality: Egyptian Position: Lecturer (Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al- Azhar University, Cairo, Egypt) Phones: +2038723783 +201514257595 E-mails: sherbinyfarag@yahoo.com sherbinyfarag@googlemail.com Address in Egypt: Pharmaceutical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, 6th district, Cairo Egypt EDUCATION Ph.D. Thesis: PhD at the University of Bonn under supervision of Prof. Dr. Christa E. Müller, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn and Fraunhofer Institut SCAI, Schloss Birlinghoven, Sankt Augustin, Germany, (2011) "The Human Adenosine A 2B Receptor: Homology Modeling, Virtual Screening, and Computer-aided Drug Design" 1

M.Sc. Thesis: Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt, (2003) "Synthesis of new Heterocyclic of Pharmaceutical Interest" B.Sc. Pharmaceutical Sciences, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt, (1995) LANGUAGES: English, German GENERAL AREAS OF INTEREST AND EXPERTISE: HOMOLOGY MODELING AND DRUG DESIGN The following are hands-on experience and skills proven by track of publication, conference abstracts and teaching: 1. Experience in Computational Chemistry and Molecular Modeling applied to Structurebased and Ligand-based drug discovery 2. Experience in performing Molecular Docking (FlexX, AutoDock and Schrodinger) and MD Simulations (in Phospholipid Bilayers) (using Amber and Gromacs) 3. Experience in Homology Modeling (MOE, Sybyl), Pharmacophore Search and High Throughput Screening 4. Protein Structure and Sequence Analysis (ClustalW, BLAST) 5. Rational Design (QSAR, Molecular Dynamics, De Novo Design) 6. Structure manipulation programs (JalView, UCSF Chimera and Pymol) 7. Experience in UNIX/Linux-based platform 8. Organic Chemistry TEACHING ACTIVITIES Laboratory Demonstration and Tutoring Organic, Analytical and Pharmaceutical Chemistry for undergraduate pharmacy students in the College of Pharmacy, Al-Azhar University, Cairo, Egypt (1997-2006) ACTIVITIES AS A SCIENCE REVIEWER European Journal of Medicinal Chemistry 2

PUBLICATIONS 1. A. A. El-Helby, M. A. Amin, M. M. El-Sawah, A. A. Bayomi, Adel S. El-Azab and Farag F. Sherbiny Synthesis and Microbiological Testing of Some new Derivatives of Compounds Containing Active Methylene Group J. Saudi Chem. Soc. 2006, 10, 77-94 2. Farag F. Sherbiny, Anke C. Schiedel, Astrid Maaß, and Christa E. Müller Homology modelling of the human adenosine A 2B receptor based on X ray structures of bovine rhodopsin, the β 2 -adrenergic receptor and the human adenosine A 2A receptor J. Comput. Aided Mol. Des. 2009, 23, 807-828 3. Anke C. Schiedel, Dominik Thimm, Sonja Hinz, Farag F. Sherbiny, Thomas Borrmann, Astrid Maaß, Christa E Müller Adenosine A( 2B ) receptors: Mutagenesis, modeling and new ligands to study drug-receptor interaction and activation. Third joint Italian-German Purine Club meeting: Purinergic receptors: new frontiers for novel therapies Purinergic signaling 2010, 6, 69 4. Anke Schiedel, Dominik T. Thimm, Sonja Hinz, Farag Sherbiny, Thomas Borrmann, Astrid Maaß, Christa E. Müller Importance of selected amino acid residues of the human adenosine A 2B receptor for ligand binding and receptor activation. Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine. Purinergic Signal. 2010, 6, S36-S37 5. Mohamed-Kamal Ibrahim, Ashraf A. Abd-Elrahman, Rezk R. A. Ayyad, Khaled El-Adl, Farag F Sherbiny, Mahmoud Rashed Design and synthesis of some novel N-phthalimide derivatives with potential anticonvulsant activity Az. J. Pharm. Sci. 2010, 42, 305-322 6. Anke C. Schiedel, Sonja Hinza, Dominik Thimm, Farag Sherbiny, Thomas Borrmann, Astrid Maaß and Christa E. Müller The four cysteine residues in the second extracellular loop of the human adenosine A 2B receptor: role in ligand binding and receptor function Biochem. Pharmacol. 2011, 82,389-399. 7. Sonja Hinz, Anke C. Schiedel, Dominik Thimm, Farag Sherbiny, Thomas Borrmann, AstridMaaß, and Christa E. Müller One is all it takes: disulfide bonds and cysteine residues in the extracellular loop 2 of the adenosine A 2B receptor. Abstracts of the Fourth Joint German-Italian Purine Club Meeting 2011 Purinergic Signalling 2012, 8, 174 8. Dominik Thimm, Anke C. Schiedel, Farag F. Sherbiny, Sonja Hinz, Katharina Hochheiser, Daniela C. G. Bertarelli, Astrid Maas, and Christa E. Muller. Ligand-specific binding and activation of the human adenosine A 2B receptor. Biochemistry, 2013 (accepted) 9. Benjamin F. Seibt, Anke C. Schiedel, Dominik Thimm, Sonja Hinz, Farag F. Sherbiny, Astrid Maas, and Christa E. Muller. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange studies at A2 adenosine receptors. Biochemical Journal (submitted) CONFERENCE ATTENDED AND POSTER PRESENTATIONS 3

1- A. A. El-Helby, M. A. Amin, M. M. El-Sawah, A. A. Bayomi, and Farag F. Sherbiny. Synthesis of new Heterocyclic of Pharmaceutical Interest. Al-Azhar 2nd International Conference for Pharmaceutical and Biological Sciences 2003, Cairo, Egypt 2- Farag F. Sherbiny, Anke C. Schiedel, Astrid Maaß, and Christa E. Müller. Homology modelling of the human adenosine A 2B receptor based on bovine rhodopsin and the β 2 -adrenergic receptor: comparison of the binding modes and conformational effects of agonists and antagonists. DPhG symposium, 2008, University of Bonn, Germany 3- Dominik T. Thimm, Anke C. Schiedel, Sonja Hinz, Farag Sherbiny, Astrid Maaß, Thomas Borrmann and Christa E. Müller. Role of selected amino acid residues in ligand binding and activation of the human adenosine A 2B receptor. DPhG symposium, 2008, University of Bonn, Germany 4- Farag F. Sherbiny, Anke C. Schiedel, Astrid Maaß, and Christa E. Müller. Homology modelling of the human adenosine A 2B receptor based on X-ray structures of bovine rhodopsin, the 2 -adrenergic receptor and the human adenosine A 2A receptor. Purinergic Receptors: New Frontiers for Novel Therapies, Third Joint Italian-German Purine Club Meeting July 17-20, 2009, Camerino, Italy 5- Anke C. Schiedel, Dominik Thimm, Sonja Hinz, Farag Sherbiny, Thomas Borrmann, Astrid Maaß and Christa E. Müller. Adenosine A 2B receptors: mutagenesis, modeling and new ligands to study drug-receptor interaction and activation. Purinergic Receptors: New Frontiers for Novel Therapies, Third Joint Italian-German Purine Club Meeting July 17-20, 2009, Camerino, Italy 6- Farag F. Sherbiny, Anke C. Schiedel, Astrid Maaß, and Christa E. Müller. Homology modelling of the human adenosine A 2B receptor based on X-ray structures of bovine rhodopsin, the 2 -adrenergic receptor and the human adenosine A 2A receptor. Molecular Graphics and Modelling Society ( MGMS ) International Meeting and Modelling Workshop, September 6-11, 2009, Erlangen, Germany 7- Dominik T. Thimm, Anke C. Schiedel, Katharina Hochheiser, Sonja Hinz, Farag F. Sherbiny, Astrid Maaß and Christa E. Müller. From models to mutants to drugs new insights in ligand binding and activation of the human adenosine A 2B receptor. September, 2009, Stockholm 8- Anke C. Schiedel, Dominik Thimm, Sonja Hinz, Farag Sherbiny, Astrid Maaß and Christa E. Müller. Drug-receptor interaction and activation of the human adenosine A 2B receptor and selected mutants. The EMBO Meeting, 2009, Amsterdam 9- Anke C. Schiedel, Dominik T. Thimm, Sonja Hinz, Farag Sherbiny, Thomas Borrmann, Astrid Maaß and Christa E. Müller. Importance of selected amino acid residues of the human adenosine A2B receptor for lligand binding and receptor actiivatiion. International meeting Purines 2010: adenosine nucleosides and nucleotides in biomedicine. 30 May 2010-02 Jun 2010, Tarragona, Spain 4

10- Thimm, D. T. Schiedel, A. C. Hochheiser, K. Hinz, S. Sherbiny, F. F. Maaß, A. Müller, C. E. How 2B bound new insights into ligand recognition by the human adenosine A 2B receptor. 2010, Braunschweig, Germany 11- Sonja Hinz, Anke C. Schiedel, Dominik Thimm, Farag Sherbiny, Thomas Borrmann, Astrid Maaß, and Christa E. Müller. One is all it takes: disulfide bonds and cysteine residues in the extracellular loop 2 of the adenosine A 2B receptor. International Conference on Purinergic Drugs and Targets 4th Joint German-Italian Purine Club Meeting, July 22-25, 2011, Bonn, Germany AWARDS 2006 Egyptian Government PhD scholarship 2009 Poster present, Camerino, Italy COMPUTER KNOWLEDGE ICDL Certificte SPECIAL INTERESTS REFERENCES Reading, Bing Bong, Football and Computer. Prof. Dr. Christa E. Müller University of Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I An der Immenburg 4, D-53121 Bonn (Endenich), Germany Phone: +49-(0)228-73-2301 Fax: +49-(0)228-73-2567 E-mail: christa.mueller@uni-bonn.de Prof. Dr. Michael Gütschow University of Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I An der Immenburg 4, D-53121 Bonn (Endenich), Germany Phone: +49 228 732317 Fax: +49 228 732567 E-mail: guetschow@uni-bonn.de 5